Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis

NCT05067348 is registered in ClinicalTrials.gov with Tang-Du Hospital as lead sponsor.

NCT NCT05067348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05067348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis
Lead sponsor
Tang-Du Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
July 21, 2022
Completion date
March 30, 2026
Enrollment
64 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

myasthenia gravis, generalized